TEAM & ADVISORS

Brenda Weiermair is a co-founder of NAEJA-RGM Pharmaceuticals Inc. She began her career working in the pharmaceutical industry at SynPhar Laboratories Inc. (the precursor to NAEJA Pharmaceutical Inc.) for eight years in a variety of key finance and business development management roles, and later served on the Board of Directors of NAEJA Pharmaceutical Inc. (2004-2012). For the past twenty years, Ms. Weiermair's diverse work experience has included senior finance and management positions in software, entertainment, alternative energy and electric vehicle automation, including serving as Treasurer on the Board of the California Hydrogen Business Council. Most recently she has served as the President of Earth Energy Fuels and the CFO of Land Systems Corp. Ms. Weiermair has worked for the past ten years with young companies pursuing cutting edge technologies. Her focus is on restructuring, strategy, and debt and equity raises to redirect resources, address corporate compliance issues, refocus long-term planning, and launch existing and new ventures. She holds a B.Comm. degree in Accounting & General Management, and an MBA in Finance.

Dr. Reddy has over 35 years of experience in Medicinal, Synthetic, Organic, and Process Development Chemistry. He has collaborated with large and small pharmaceutical companies in important therapeutic areas such as antimicrobials, cardiovascular, CNS, and metabolic disorders.

He is credited as an inventor on multiple patents and contributed to many publications . During his research career, Dr. Reddy was involved in several projects that successfully produced pre-clinical candidates, currently in various stages of development. He has a strong background and successful track record in Lead Generation, Lead Optimization and Candidate delivery.

He is highly knowledgeable in computer assisted drug design and small molecule drug discovery (Discover, Make, Test and Analyze) and experienced in cross functional team leadership, small and large molecule drug discovery team leadership, lead optimization and project management. He has worked across several major disease areas and has significant experience in the drug discovery and development processes.

Dr. Reddy is one of the original contributing members of Dr. Ronald G. Micetich’s core discovery team credited with important scientific discoveries.